MedX vs Spotlight Pathology
MedX vs Spotlight Pathology, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: MedX is on 45/100 and Spotlight Pathology on 42/100.
Where each one leads
MedX
- our overall score: 45/100 against 42/100
- agent readiness: 43/100 against 32/100
- domain rating: 31/100 against 14/100
- headcount: 30 against 6
- funding raised: $8.9M against $688K
Spotlight Pathology
Leads on none of the measures we hold for both companies.
At a glance
| Measure | MedX | Spotlight Pathology |
|---|---|---|
| What it is | A medical device company specializing in non-invasive skin assessment technology for early detection of melanoma and other skin cancers. | AI software for faster and more consistent identification of blood cancers. |
| Category | HealthTech, Medical Devices, Dermatology, Diagnostics | HealthTech, Artificial Intelligence, Biotechnology, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Software |
| Founded | 1999 | 2020 |
| Headquarters | Mississauga, Canada | Daresbury, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | MedX | Spotlight Pathology |
|---|---|---|
| Employees | 30 | 6 |
| Total funding | $8.9M | $688K |
| Latest round | Series IV | Seed |
| Valuation | $8.0M | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | MedX | Spotlight Pathology |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 42/100 |
| Traction | 50/100 | 38/100 |
| Search visibility | 10/100 | 6/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (43/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 31/100 | 14/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | MedX | Spotlight Pathology |
|---|---|---|
| CMS | Squarespace | Not detected |
| Analytics | Google Analytics 4 | Not detected |
| Support stack | HubSpot | Not detected |
MedX vs Spotlight Pathology: common questions
Which is better, MedX or Spotlight Pathology?
On our 0-100 score MedX rates higher (45/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do MedX and Spotlight Pathology compare on the numbers?
MedX leads on our overall score (45/100 against 42/100), agent readiness (43/100 against 32/100), domain rating (31/100 against 14/100), headcount (30 against 6), funding raised ($8.9M against $688K).
Read the full MedX review and pricing or the Spotlight Pathology review and pricing. You can also browse other MedX alternatives we track.